ABVC BioPharma Operating Expenses 2010-2025 | ABVC

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

ABVC BioPharma operating expenses from 2010 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

ABVC BioPharma operating expenses from 2010 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Related Stocks
Company Name	Market Cap
AstraZeneca (AZN)	$222.8B
Amgen (AMGN)	$162B
Gilead Sciences (GILD)	$140.6B
Vertex Pharmaceuticals (VRTX)	$118.3B
Bristol Myers Squibb (BMY)	$96.7B
CSL (CSLLY)	$85.2B
GSK (GSK)	$76.5B
Regeneron Pharmaceuticals (REGN)	$60.3B
Alnylam Pharmaceuticals (ALNY)	$42.3B
Argenex SE (ARGX)	$36.4B
BioNTech SE (BNTX)	$27.1B
Royalty Pharma (RPRX)	$20.8B
Insmed (INSM)	$19.3B
Biogen (BIIB)	$18.9B
Illumina (ILMN)	$17.4B
Genmab (GNMSF)	$15.2B
Genmab (GMAB)	$14.8B
Incyte (INCY)	$13.6B
Moderna (MRNA)	$13.1B
Exelixis (EXEL)	$12.1B
QIAGEN (QGEN)	$11.3B
BioMarin Pharmaceutical (BMRN)	$11.1B
Swedish Orphan Biovitrum (BIOVF)	$10.6B
Ascendis Pharma (ASND)	$10B
Bio-Techne Corp (TECH)	$9.2B
Exact Sciences (EXAS)	$9.1B
Verona Pharma American Depositary Share (VRNA)	$8.9B
Blueprint Medicines (BPMC)	$8.3B
Roivant Sciences (ROIV)	$7.7B
Legend Biotech (LEGN)	$7.6B